Literature DB >> 29856103

A pharmacological challenge predicts reversible rectal sensorimotor dysfunctions in women with fecal incontinence.

M Sharma1, K Feuerhak1, A R Zinsmeister2, A E Bharucha1.   

Abstract

BACKGROUND: In order to understand the pathophysiology of rectal sensorimotor dysfunctions in women with fecal incontinence (FI) and rectal urgency, we evaluated the effects of a muscarinic antagonist and an adrenergic α2 agonist on these parameters.
METHODS: Firstly, rectal distensibility and sensation were evaluated with a barostat and sinusoidal oscillation at baseline and after randomization to intravenous saline or atropine in 16 healthy controls and 44 FI patients. Thereafter, FI patients were randomized to placebo or clonidine for 4 wk; rectal compliance and sensation were revaluated thereafter. The effect of atropine and clonidine on rectal functions and the relationship between them were evaluated.
RESULTS: At baseline, compared to controls, rectal capacity was lower (P = .03) while the mean pressure (P = .02) and elastance (P = .01) during sinusoidal oscillation were greater, signifying reduced distensibility, in FI. Compared to placebo, atropine increased (P ≤ .02) the heart rate in controls and FI and reduced (P = .03) the variability in rectal pressures during sinusoidal oscillation in controls. Clonidine increased rectal compliance (P = .04) and reduced rectal capacity (P = .03) in FI. The effects of atropine and clonidine on compliance (r = .44, P = .003), capacity (r = .34, P = .02), pressures during sinusoidal oscillation (r = .3, P = .057), pressure (r = .6, P < .0001), and volume sensory thresholds (r = .48, P = .003) were correlated.
CONCLUSIONS: The effects of atropine and clonidine on rectal distensibility and sensation were significantly correlated. A preserved response to atropine suggests that reduced rectal distensibility is partly reversible, mediated by cholinergic mechanisms, and may predict the response to clonidine, providing a pharmacological challenge.
© 2018 John Wiley & Sons Ltd.

Entities:  

Keywords:  atropine; clonidine; fecal incontinence; rectal capacity; rectal compliance; urgency

Mesh:

Substances:

Year:  2018        PMID: 29856103      PMCID: PMC6160337          DOI: 10.1111/nmo.13383

Source DB:  PubMed          Journal:  Neurogastroenterol Motil        ISSN: 1350-1925            Impact factor:   3.598


  30 in total

1.  Rectal augmentation and stimulated gracilis anal neosphincter: a new approach in the management of fecal urgency and incontinence.

Authors:  N S Williams; O A Ogunbiyi; S M Scott; O Fajobi; P J Lunniss
Journal:  Dis Colon Rectum       Date:  2001-02       Impact factor: 4.585

2.  Magnetic resonance imaging of the rectum during distension.

Authors:  Annalisa Dal Lago; Alberto E Minetti; Pietro Biondetti; Maura Corsetti; Guido Basilisco
Journal:  Dis Colon Rectum       Date:  2005-06       Impact factor: 4.585

3.  Effect of aging on anorectal and pelvic floor functions in females.

Authors:  Jean C Fox; Joel G Fletcher; Alan R Zinsmeister; Barb Seide; Stephen J Riederer; Adil E Bharucha
Journal:  Dis Colon Rectum       Date:  2006-11       Impact factor: 4.585

4.  Effect of nifedipine on anorectal sensorimotor functions in health and fecal incontinence.

Authors:  Adil E Bharucha; Jessica Edge; Alan R Zinsmeister
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-04-14       Impact factor: 4.052

5.  The effects of clonidine on symptoms and anorectal sensorimotor function in women with faecal incontinence.

Authors:  A E Bharucha; B M Seide; A R Zinsmeister
Journal:  Aliment Pharmacol Ther       Date:  2010-09       Impact factor: 8.171

Review 6.  High amplitude propagated contractions.

Authors:  A E Bharucha
Journal:  Neurogastroenterol Motil       Date:  2012-11       Impact factor: 3.598

7.  Contractile response to colonic distention is influenced by oscillation frequency.

Authors:  A E Bharucha; S Dhamija; A Japp; B Seide; B Walters; R Stroetz; A R Zinsmeister; R D Hubmayr
Journal:  Neurogastroenterol Motil       Date:  2005-02       Impact factor: 3.598

8.  Rectal hypersensitivity worsens stool frequency, urgency, and lifestyle in patients with urge fecal incontinence.

Authors:  Christopher L H Chan; S Mark Scott; Norman S Williams; Peter J Lunniss
Journal:  Dis Colon Rectum       Date:  2005-01       Impact factor: 4.585

9.  Inhibitory control of proximal colonic motility by the sympathetic nervous system.

Authors:  R A Gillis; J Dias Souza; K A Hicks; A W Mangel; F D Pagani; B L Hamilton; T Q Garvey; D G Pace; R K Browne; W P Norman
Journal:  Am J Physiol       Date:  1987-10

10.  Effect of atropine on the biomechanical properties of the oesophageal wall in humans.

Authors:  Torahiko Takeda; Ghassan Kassab; Jianmin Liu; Toshinaga Nabae; Ravinder K Mittal
Journal:  J Physiol       Date:  2003-01-10       Impact factor: 5.182

View more
  4 in total

1.  Relationship between symptoms during a gastric emptying study and intestinal chemosensitivity with daily symptoms.

Authors:  Subhankar Chakraborty; Anshuman Desai; Magnus Halland; Duane Burton; Michael Camilleri; Alan R Zinsmeister; Adil E Bharucha
Journal:  Neurogastroenterol Motil       Date:  2019-07-21       Impact factor: 3.598

Review 2.  Faecal incontinence in adults.

Authors:  Adil E Bharucha; Charles H Knowles; Isabelle Mack; Allison Malcolm; Nicholas Oblizajek; Satish Rao; S Mark Scott; Andrea Shin; Paul Enck
Journal:  Nat Rev Dis Primers       Date:  2022-08-10       Impact factor: 65.038

Review 3.  Critical appraisal of international guidelines for the management of fecal incontinence in adults: is it possible to define what to do in different clinical scenarios?

Authors:  A Muñoz-Duyos; L Lagares-Tena; Y Ribas; J C Baanante; A Navarro-Luna
Journal:  Tech Coloproctol       Date:  2021-11-12       Impact factor: 3.781

4.  A new method for assessing anal distensibility with a barostat and magnetic resonance imaging in healthy and constipated women.

Authors:  Mayank Sharma; Kelly Feuerhak; Stephen M Corner; Armando Manduca; Adil E Bharucha
Journal:  Neurogastroenterol Motil       Date:  2020-08-19       Impact factor: 3.598

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.